The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(4,5-dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole ID: ALA1650576
PubChem CID: 53323189
Max Phase: Preclinical
Molecular Formula: C20H19N5
Molecular Weight: 329.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: DB1172 | CHEMBL1650576|DB1172
Canonical SMILES: c1cc(-c2cc3cc(C4=NCCN4)ccc3[nH]2)ccc1C1=NCCN1
Standard InChI: InChI=1S/C20H19N5/c1-3-14(19-21-7-8-22-19)4-2-13(1)18-12-16-11-15(5-6-17(16)25-18)20-23-9-10-24-20/h1-6,11-12,25H,7-10H2,(H,21,22)(H,23,24)
Standard InChI Key: SQNGJMVHBDDXKF-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 29 0 0 0 0 0 0 0 0999 V2000
7.3933 -3.0077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3933 -3.8363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1069 -4.2483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1069 -2.5911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8252 -3.0077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8297 -3.8373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6202 -4.0893 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1041 -3.4154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6127 -2.7471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9314 -3.4086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3460 -4.1218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1665 -4.1192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5784 -3.4051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1637 -2.6919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3370 -2.6929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4024 -3.4036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6785 -2.5978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8881 -4.0657 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6713 -3.8097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6698 -2.9856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8856 -2.7325 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6662 -1.7780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8792 -1.5336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4035 -2.2065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8966 -2.8667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 4 2 0
2 3 2 0
10 15 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
8 10 1 0
3 6 1 0
13 16 1 0
6 7 1 0
1 17 1 0
16 18 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
18 19 1 0
19 20 1 0
20 21 1 0
21 16 2 0
17 22 2 0
5 4 1 0
5 6 2 0
1 2 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 17 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 329.41Molecular Weight (Monoisotopic): 329.1640AlogP: 2.53#Rotatable Bonds: 3Polar Surface Area: 64.57Molecular Species: BASEHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.71CX LogP: 2.14CX LogD: -1.56Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.69Np Likeness Score: -0.54
References 1. Gillingwater K, Kumar A, Anbazhagan M, Boykin DW, Tidwell RR, Brun R.. (2009) In vivo investigations of selected diamidine compounds against Trypanosoma evansi using a mouse model., 53 (12): [PMID:19786604 ] [10.1128/aac.00422-09 ]